Core Viewpoint - China Feihe (06186.HK) announced a share buyback of 5.885 million shares at a cost of HKD 23.6977 million, with a buyback price ranging from HKD 4.2 to HKD 4.3 per share [1] Group 1 - The company executed a buyback on October 24, 2025 [1] - The total expenditure for the buyback was HKD 23.6977 million [1] - The number of shares repurchased was 5.885 million [1]

Core Viewpoint - China Feihe (06186) announced a share buyback plan, investing HKD 23.6977 million to repurchase 5.885 million shares on October 24, 2025 [1] Group 1 - The company is engaging in a share repurchase, indicating confidence in its own stock value [1] - The total amount allocated for the buyback is approximately HKD 23.7 million [1] - The number of shares to be repurchased is 5.885 million [1]

表格類別： 股票 狀態： 新提交 公司名稱： 中國飛鶴有限公司 呈交日期： 2025年10月24日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06186 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | | | | 於 ...

Core Viewpoint - China Feihe (06186.HK) has seen a stock price increase of over 3%, currently trading at 4.11 HKD with a transaction volume of 129 million HKD [2] Summary by Category - **Stock Performance** - The stock price of China Feihe has risen by 3.27% [2] - Current trading price is 4.11 HKD [2] - Total transaction volume reached 129 million HKD [2]

Core Viewpoint - China Feihe (06186) has seen a stock price increase of over 3%, currently trading at 4.11 HKD with a transaction volume of 129 million HKD, driven by the acceleration of local childcare subsidy approvals [1] Group 1: Company Performance - China Feihe is recognized as a leading player in the Chinese infant formula market, with a continuously increasing market share and solid brand and channel advantages [1] - The company is expected to experience a significant revenue recovery by the second half of 2025, aided by the completion of channel adjustments and the introduction of new products, alongside the positive impact of the childcare subsidy policy [1] Group 2: Market Context - Reports indicate that many parents in regions such as Sichuan and Chongqing have had their childcare subsidy applications approved, with local governments speeding up the review process [1] - Different regions have varying timelines for the disbursement of these subsidies, with places like Xining expected to issue the first batch of funds by the end of October, while others may do so in November or December [1]

Core Viewpoint - China Feihe (06186) shares rose over 3%, currently at 4.11 HKD with a trading volume of 129 million HKD, driven by the acceleration of local childcare subsidy approvals [1] Group 1: Company Performance - China Feihe's market share in the infant formula sector continues to increase, supported by strong brand and channel advantages [1] - The company is expected to see revenue recovery in the second half of 2025, aided by channel adjustments and new product launches, alongside the positive impact of the childcare subsidy policy [1] Group 2: Industry Context - Local childcare subsidy approvals are speeding up, with varying distribution timelines across regions; for instance, Xining plans to distribute the first batch of subsidies by the end of October, while other areas may do so in November or December [1]

中國飛鶴有限公司 （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：6186） 持續關連交易 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 China Feihe Limited 北緯四十七度採購框架協議 北緯四十七度採購框架協議 於2025年10月14日，黑 龍 江 飛 鶴 與 北 緯 四 十 七 度 訂 立 北 緯 四 十 七 度 採 購 框 架 協 議。據 此，黑 龍 江 飛 鶴 同 意 從2025年10月14日 至2027年12月31日 期 間，通 過 其 附 屬 公 司 直 接 或 間 接 向 北 緯 四 十 七 度 及╱或 其 附 屬 公 司 採 購 若 干 農 產 品。 上市規則的涵義 於 本 公 告 日 期，北 緯 四 十 七 度 主 要 由 本 公 司 執 行 董 事、董 事 會 主 席 兼 行 政 總裁及控股股東（定 義 見 上 市 規 則）冷 ...

Core Viewpoint - The launch of "New Generation More Suitable" by Feihe Milk Powder emphasizes the company's commitment to developing products tailored to the physical needs of Chinese babies, showcasing significant advancements in research and product offerings [1][3]. Group 1: Product Innovation - Feihe has introduced a unique "Fresh Nutrition System," which focuses on fresh milk sources, raw materials, and production processes to enhance the nutritional quality of its products [5]. - The company has established a "2-hour ecological circle" for rapid low-temperature transportation of fresh milk to factories, ensuring the preservation of active nutrients [5]. - Feihe's new products, including Qicui and Jicui, aim to replicate the nutritional ecosystem of breast milk, enhancing the potential of infants [8]. Group 2: Research and Development - Feihe has been a pioneer in clinical feeding research for infants since 2010, with its flagship product, Xingfeifan, demonstrating growth and development outcomes comparable to breastfed infants [10]. - The company has developed a "Chinese Maternal Source Bionic Formula," closely aligning with the composition of Chinese breast milk, including a significant proportion of Sn-2 DHA [13]. - Feihe has received multiple authoritative certifications, including being the top brand in Chinese maternal source formula nutrition and infant formula patents [14]. Group 3: Market Position and Consumer Trust - Feihe has achieved the highest sales in the infant formula market in China for six consecutive years and globally for four years [14]. - The company has built a trusted platform, "Xingma Club," which provides scientific feeding guidance to over 85 million Chinese mothers [14]. - Feihe's commitment to addressing the needs of mothers has been recognized, with initiatives like "China Baby Day" and financial support for families [14][17].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | | --- | | 2025年9月30日 | | 狀態: | | 新提交 | 致：香港交易及結算所有限公司 公司名稱: 中國飛鶴有限公司 呈交日期: 2025年10月6日 第 1 頁 共 10 頁 v 1.1.1 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06186 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000,000 | USD | 0.000000025 | USD | | 50,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 2,000,000,000,000 | USD | 0 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 China Feihe Limited 中國飛鶴有限公司 （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：6186） 須予披露交易 認購金融產品 認購金融產品 茲 提 述 本 公 司 日 期 為 二 零 二 四 年 十 一 月 十 二 日、二 零 二 四 年 十 二 月 九 日 及 二 零 二 四 年 十 二 月 三 十 日 的 公 告，內 容 有 關（其 中 包 括）本集團認購若干中信銀行 的理財及結構性存款金融產品（「認購中信銀行金融產品」）。 董 事 會 宣 佈，於 二 零 二 五 年 九 月 二 十 四 日，本 公 司 全 資 附 屬 公 司 黑 龍 江 飛 鶴 以其閑置資金認購若干中信銀行發售的金額分別為人民幣300百萬元及人民幣 100百萬元的理財金融產品（「認購信銀產品」）。下 表 載 列 認 購 信 銀 ...